QUAY STEVEN C 4
4 · ATOSSA THERAPEUTICS, INC. · Filed May 18, 2021
Insider Transaction Report
Form 4
QUAY STEVEN C
DirectorPresident & CEO
Transactions
- Award
Stock Option (right to buy)
2021-05-14+1,900,000→ 1,900,000 totalExercise: $2.90Exp: 2031-05-14→ Common Stock (1,900,000 underlying)
Footnotes (1)
- [F1]The options will vest on a quarterly basis over the next 24 months. Option grant was issued at 4:30 p.m. (ET) on May 14, 2021 with an exercise price of $2.90, representing the most recently reported closing stock price at the time of grant.